Medicalgorithmics signs contract with US IDTF with estimated revenue potential of up to PLN 46 million over two years. The Agreement covers the provision of specific services and the licensing of Medicalgorithmics’s leading software, DeepRhythmPlatform (DRP), equipped with DeepRhythmAI (DRAI) artificial intelligence algorithms for ECG signal analysis from the Partner’s (IDTF’s) devices.
Medicalgorithmics on a dynamic growth path in Q3 2023. Revenue up 38% y/y, driven by sales in the US: +76% y/y.
Medicalgorithmics, listed on the Warsaw Stock Exchange and a developer of globally innovative AI algorithms used